Randomized multicenter phase II trial evaluating the sequencing of PD-1 inhibition with pembrolizumab (P) and standard platinum-based chemotherapy (C) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) (AFT-09).
Hensing, TA; Wang, XF; Gao, J; Stinchcombe, T; Knopp, MV; Dudek, AZ; Graziano, SL; Patel, JD; Faller, B; Dragnev, KH; Kozono, DE; Vokes, EE
Volume / Issue
Electronic International Standard Serial Number (EISSN)
International Standard Serial Number (ISSN)
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference Start Date
Conference End Date